section name header

Y-Site Injection Compatibility (1:1 Mixture)

Piperacillin sodium-tazobactam sodium

(Mfr: CYg)(Conc: 40 mg/mLa,i)

I

Doxorubicin HCl liposomal

(Mfr: SEQ)(Conc: 0.4 mg/mLa)

Remarks:

Partial loss of measured natural turbidity

Ref:

2087